| Montowese Health & Rehabilitation Center | |
| 163 Quinnipiac Avenue, North Haven, Connecticut 06473 | |
| (203) 624-3303 | |
| Name | Montowese Health & Rehabilitation Center |
|---|---|
| Location | 163 Quinnipiac Avenue, North Haven, Connecticut |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 120 |
| Occupancy Rate | 88.08% |
| Medicare ID (CCN) | 075017 |
| Legal Business Name | Athena Montowese Snf, Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1467401075 |
| Organization Name | MONTOWESE HEALTH & REHABILILTATION CENTER |
| Address | 163 Quinnipiac Ave, North Haven, CT 06473 |
| Phone Number | 203-624-3303 |
News Archive
A new target for control of early-stage asthma has been identified by McGill University professor Qutayba Hamid working as part of a team whose landmark study appears in the latest issue of the journal Science
Results of a clinical trial conducted in a largely self-contained religious community during the 2008-09 influenza season show that immunizing children against seasonal influenza can significantly protect unvaccinated community members against influenza as well. The study was conducted to determine if immunized children could act as a barrier to limit the spread of influenza to the wider, unvaccinated community, a concept known as herd immunity.
Angiochem announced today that the Food & Drug Association (FDA) has granted both orphan drug and fast track designation to ANG1005 a novel paclitaxel-peptide drug conjugate leveraging the low density lipoprotein receptor-related protein 1 (LRP-1) pathway to cross the blood-brain barrier (BBB) and enter cancer, for the treatment of glioblastoma multiforme (GBM).
Hospital for Special Surgery announced the receipt of a $5 million commitment from CA Technologies, an IT management software and solutions company, at its 27th Annual Tribute Dinner at the Waldorf Astoria on June 21, 2010.
› Verified 6 days ago
| NPI Number | 1629826912 |
| Organization Name | MONTOWESE ACQUISITION OPERATOR, LLC |
| Address | 163 Quinnipiac Ave, North Haven, CT 06473 |
| Phone Number | 516-705-4800 |
News Archive
A new target for control of early-stage asthma has been identified by McGill University professor Qutayba Hamid working as part of a team whose landmark study appears in the latest issue of the journal Science
Results of a clinical trial conducted in a largely self-contained religious community during the 2008-09 influenza season show that immunizing children against seasonal influenza can significantly protect unvaccinated community members against influenza as well. The study was conducted to determine if immunized children could act as a barrier to limit the spread of influenza to the wider, unvaccinated community, a concept known as herd immunity.
Angiochem announced today that the Food & Drug Association (FDA) has granted both orphan drug and fast track designation to ANG1005 a novel paclitaxel-peptide drug conjugate leveraging the low density lipoprotein receptor-related protein 1 (LRP-1) pathway to cross the blood-brain barrier (BBB) and enter cancer, for the treatment of glioblastoma multiforme (GBM).
Hospital for Special Surgery announced the receipt of a $5 million commitment from CA Technologies, an IT management software and solutions company, at its 27th Annual Tribute Dinner at the Waldorf Astoria on June 21, 2010.
› Verified 6 days ago
| NPI Number | 1710499066 |
| Organization Name | ATHENA MONTOWESE SNF LLC |
| Doing Business As | ATHENA HEALTH CARE SYSTEMS |
| Address | 163 Quinnipiac Ave, North Haven, CT 06473 |
| Phone Number | 203-624-3303 |
News Archive
A new target for control of early-stage asthma has been identified by McGill University professor Qutayba Hamid working as part of a team whose landmark study appears in the latest issue of the journal Science
Results of a clinical trial conducted in a largely self-contained religious community during the 2008-09 influenza season show that immunizing children against seasonal influenza can significantly protect unvaccinated community members against influenza as well. The study was conducted to determine if immunized children could act as a barrier to limit the spread of influenza to the wider, unvaccinated community, a concept known as herd immunity.
Angiochem announced today that the Food & Drug Association (FDA) has granted both orphan drug and fast track designation to ANG1005 a novel paclitaxel-peptide drug conjugate leveraging the low density lipoprotein receptor-related protein 1 (LRP-1) pathway to cross the blood-brain barrier (BBB) and enter cancer, for the treatment of glioblastoma multiforme (GBM).
Hospital for Special Surgery announced the receipt of a $5 million commitment from CA Technologies, an IT management software and solutions company, at its 27th Annual Tribute Dinner at the Waldorf Astoria on June 21, 2010.
› Verified 6 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
A new target for control of early-stage asthma has been identified by McGill University professor Qutayba Hamid working as part of a team whose landmark study appears in the latest issue of the journal Science
Results of a clinical trial conducted in a largely self-contained religious community during the 2008-09 influenza season show that immunizing children against seasonal influenza can significantly protect unvaccinated community members against influenza as well. The study was conducted to determine if immunized children could act as a barrier to limit the spread of influenza to the wider, unvaccinated community, a concept known as herd immunity.
Angiochem announced today that the Food & Drug Association (FDA) has granted both orphan drug and fast track designation to ANG1005 a novel paclitaxel-peptide drug conjugate leveraging the low density lipoprotein receptor-related protein 1 (LRP-1) pathway to cross the blood-brain barrier (BBB) and enter cancer, for the treatment of glioblastoma multiforme (GBM).
Hospital for Special Surgery announced the receipt of a $5 million commitment from CA Technologies, an IT management software and solutions company, at its 27th Annual Tribute Dinner at the Waldorf Astoria on June 21, 2010.
› Verified 6 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 3 |
| Total Amount of Fines in Dollars | $23855 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 3 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 19.78 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 4.24 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 35 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.88 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.71 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 8.81 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 69.43 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 8.67 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 47.34 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.89 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 40.73 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 27.32 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 7.48 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 86.84 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 67.76 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 52.09 | 82.93 |
News Archive
A new target for control of early-stage asthma has been identified by McGill University professor Qutayba Hamid working as part of a team whose landmark study appears in the latest issue of the journal Science
Results of a clinical trial conducted in a largely self-contained religious community during the 2008-09 influenza season show that immunizing children against seasonal influenza can significantly protect unvaccinated community members against influenza as well. The study was conducted to determine if immunized children could act as a barrier to limit the spread of influenza to the wider, unvaccinated community, a concept known as herd immunity.
Angiochem announced today that the Food & Drug Association (FDA) has granted both orphan drug and fast track designation to ANG1005 a novel paclitaxel-peptide drug conjugate leveraging the low density lipoprotein receptor-related protein 1 (LRP-1) pathway to cross the blood-brain barrier (BBB) and enter cancer, for the treatment of glioblastoma multiforme (GBM).
Hospital for Special Surgery announced the receipt of a $5 million commitment from CA Technologies, an IT management software and solutions company, at its 27th Annual Tribute Dinner at the Waldorf Astoria on June 21, 2010.
› Verified 6 days ago
Montowese Health & Rehabilitation Center Location: 163 Quinnipiac Avenue, North Haven, Connecticut 06473 Phone: (203) 624-3303 |